HERVs have gained large interest in neurodegenerative diseases in general and in MS in particular, notably as disease markers and putative targets for MS therapy [84–86], with a still unclear role of HERV-R [87,88]. This evidence concerns the gene ERV3-1 and neurodegenerative disease.